Recent Finacing
Recent Raise
FundaMental Pharma is a Heidelberg spin‑out developing small‑molecule interface inhibitors that block NMDA receptor–TRPM4 coupling to prevent glutamate excitotoxicity, advancing compounds toward clinical testing for ALS, Huntington’s and dementia.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors